Morgan Stanley (MS)
Quote, stock score, analyst consensus, and SEC filings, plus insider and Congress trades when there are any.
NYSE · Price as of · Nasdaq Real Time Price
- Analysts22
- Implied upside+13.2%
- Target range$185.00 to $262.00
- EPS expected$2.94 +9.6%
- A year ago$2.68
- Revenue expected$20.37B +14%
- Estimate range$2.72 to $3.22
How Congress has done in MS
Every purchase of MS disclosed by a member of Congress in the last 5 years, scored over the 12 months after the trade date against SPY over the same window.
| Measure | MS | SPY |
|---|---|---|
| Median 12-month return after purchase | +24.2% | +24.2% |
| Median difference vs SPY | +2.2% | — |
| Purchases that beat SPY | 6 of 12 (50%) | — |
| Members who bought | 7 | — |
Most frequent buyers: Marjorie Taylor Greene (4), Michael Guest (3), Gil Cisneros (1), Greg Stanton (1), Josh Gottheimer (1).
These are not returns anyone actually earned. Disclosures report a dollar bracket and no share count, so every purchase is counted once and weighted equally, and sales are not matched back to the buys that opened them. 4 of the 12 purchases are disclosed as a spouse's or dependent's rather than the member's own. Purchases from the last 12 months are excluded because their window has not closed yet.
Congress trades in MS
| Date | Member | Action | Amount | |
|---|---|---|---|---|
| 2026-10-02 | Ro Khanna CA | Sale | $1,001 - $15,000 | |
| 2026-07-10 | Dan Newhouse WA | Purchase | $1,001 - $15,000 | |
| 2026-03-27 | Alan Armstrong OK | Purchase | $1,001 - $15,000 |
SEC filings
| Form | Filed | Description |
|---|---|---|
| 424B2 | November 10, 2026 | PRELIMINARY PRICING SUPPLEMENT NO. 20,026 |
| FWP | November 10, 2026 | FREE WRITING PROSPECTUS TO PRELIMINARY PRICING SUPPLEMENT NO. 20,018 |
| 424B2 | November 10, 2026 | PRELIMINARY PRICING SUPPLEMENT NO. 20,018 |
| 424B2 | November 10, 2026 | PRELIMINARY PRICING SUPPLEMENT NO. 20,025 |
| FWP | November 10, 2026 | FREE WRITING PROSPECTUS TO PRELIMINARY PRICING SUPPLEMENT NO. 20,022 |
| 424B2 | November 10, 2026 | PRELIMINARY PRICING SUPPLEMENT NO. 20,028 |
| 424B2 | November 10, 2026 | PRELIMINARY PRICING SUPPLEMENT NO. 20,021 |
| 424B2 | November 10, 2026 | PRELIMINARY PRICING SUPPLEMENT NO. 20,020 |
Articles that mention Morgan Stanley without it being the main subject.
Broadcom (AVGO) is backing the chips in a $63 billion financing for Anthropic's leases
Broadcom is giving residual value support, equal to the first lien, to a $63 billion vehicle that will lease its chips to Anthropic. Broadcom's 8-K puts its maximum exposure at about $43 billion.
Anthropic files for a Nasdaq IPO as ANT, showing $16.3 billion in first-half revenue and an $80.7 billion loss
Most of the loss is an accounting charge. The filing also shows who will control Anthropic and how big its SpaceX computing bill is about to get.
AI chipmaker Tenstorrent raises $1.5 billion at a $6.2 billion valuation, with Sandisk (SNDK) among backers
Jim Keller's chip company more than doubled its valuation months after reported takeover interest from Intel and Qualcomm. Here's who invested and where the money goes.
Frequently asked questions
When does MS report earnings?
Morgan Stanley (MS) is scheduled to report quarterly results on January 14, 2027 (estimated). The 16-analyst consensus is $2.94 per share on revenue of $20.37B for the quarter ending December 31, 2026, against $2.68 and $17.89B a year earlier. It has beaten the consensus EPS estimate in all four of the last four quarters. The date is an estimate from past reporting patterns and can move until the company confirms it.
What do analysts expect for MS?
22 analysts cover Morgan Stanley (MS). The consensus rating is Buy. The average price target is $211.50, in a range of $185.00 to $262.00.
Are insiders buying or selling MS?
We have no qualifying Form 4 insider purchases or sales on record for Morgan Stanley (MS). Sales are only tracked above a dollar threshold, so small routine trades may not appear.
Has Congress made money trading MS?
7 members of Congress have disclosed buying MS in the last 5 years, 12 purchases in total. Measured over the 12 months after each trade date, the median purchase returned +24.2% against +24.2% for SPY over the same windows, and 6 of the 12 (50%) beat the index. These are not returns anyone actually earned: congressional disclosures report a dollar bracket and no share count, so each purchase is counted once and weighted equally, and later sales are not matched back to the buys that opened them.
Where can I see MS SEC filings?
Recent filings are listed on this page, newest first. The latest is a 424B2 filed November 10, 2026.